Avicanna's Shares Drop On Patent Application For Oral Cannabinoid Technology For Neurological Disorders
Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE:0NN) revealed Monday that it has filed a provisional patent application in the United States Patent and Trademark Office for novel technology for the treatment of various neurological diseases and disorders
